F NMR spectra S2 1.1. tert-butyl 3-iodoazetidine-1-carboxylate (6) S2 1.2. 1-amino-2,3-dibromopropane hydrobromide in D2O (17) S4 1.3. 1-amino-2,3-dibromopropane hydrobromide in MeOD (17) S6 1.4. 3-iodo-1-tosylazetidine (19) S8 1.5. tert-butyl 3-bromoazetidine-1-carboxylate (20) S10 1.6. (9H-fluoren-9-yl)methyl 3-bromoazetidine-1-carboxylate (21) S12 1.7. tert-butyl 3-cyanoazetidine-1-carboxylate (22) S14 1.8. 1-(tert-butoxycarbonyl)azetidine-3-carboxylic acid (23) S16 1.9. tert-butyl 3-hydroxyazetidine-1-carboxylate (24) S18 1.10. tert-butyl 3-benzoylazetidine-1-carboxylate (25) S20 1.11. tert-butyl 3-cyano-3-methylazetidine-1-carboxylate (26) S22 1.12. 1-(tert-butoxycarbonyl)-3-methylazetidine-3-carboxylic acid (27) S24 The X-ray diffraction data were measured on Bruker D8 Venture PHOTON 100 CMOS system equipped with a Cu Kα INCOATEC ImuS micro-focus source (λ = 1.54178 Å). Indexing was performed using Apex3 [1] . Data integration and reduction were performed using SaintPlus 6.01 [2] . Absorption correction was performed by multi-scan method implemented in SADABS [3] . Space group was determined using XPREP implemented in APEX3 [1] . Structure was solved using SHELXT [4] and refined using SHELXL-2017 [5] [6] [7] (full-matrix leastsquares on F 2 ) through OLEX2 interface program [8] . All non-hydrogen atoms were refined anisotropically. Hydrogen atoms were placed in geometrically calculated positions and were included in the refinement process using riding model with isotropic thermal parameters. -CF3 group was modeled as disordered over two positions and was refined using restraints. Crystal data and refinement conditions are shown in Table 1 . Figure S1 . Asymmetric unit of YJ_1_245_2. Anisotropic displacement parameters were drawn at 50% probability. CF3 group is disordered over two positions. 
